<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Nutrition support in intubated critically ill adult patients: Enteral nutrition</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Nutrition support in intubated critically ill adult patients: Enteral nutrition</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Nutrition support in intubated critically ill adult patients: Enteral nutrition</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Seres, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Polly E Parsons, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Geraldine Finlay, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 29, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Enteral nutrition (EN) support refers to the provision of calories, protein, electrolytes, vitamins, minerals, trace elements, and fluids via an intestinal route. EN is the most common mode of delivery for nutrition support in intubated critically ill patients. To initiate EN, appropriate access must be obtained and the prescription needs to be determined.</p><p>Typical access used, available formulations and their composition, delivery route, and monitoring of EN in critically ill patients are reviewed in this topic. The indications, contraindications, timing, and prescription of calories and protein are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1617.html" rel="external">"Nutrition support in intubated critically ill adult patients: Initial evaluation and prescription"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">INDICATIONS AND CONTRAINDICATIONS</span><span class="headingEndMark"> — </span>Clinical practice guidelines suggest that EN protocols be designed and implemented in each institution [<a href="#rid1">1,2</a>]. The indications and contraindications  (<a class="graphic graphic_table graphicRef143318" href="/z/d/graphic/143318.html" rel="external">table 1</a>) for EN are described elsewhere. (See  <a class="medical medical_review" href="/z/d/html/1617.html" rel="external">"Nutrition support in intubated critically ill adult patients: Initial evaluation and prescription", section on 'Assess indications and contraindications'</a>.)</p><p class="headingAnchor" id="H4"><span class="h1">ROUTE OF DELIVERY</span><span class="headingEndMark"> — </span>In critically ill patients, EN is most commonly delivered into the stomach (gastric feeding) (see <a class="local">'Gastric'</a> below). However, in select patients it can also be administered into more distal parts of the alimentary tract (eg, post-pyloric feeding) (see <a class="local">'Post-pyloric'</a> below). Feeding through an enteral tube should not begin until its proper position has been confirmed radiographically.</p><p class="headingAnchor" id="H5"><span class="h2">Gastric</span><span class="headingEndMark"> — </span>Gastric feeding is typically delivered via an orogastric or nasogastric tube  (<a class="graphic graphic_table graphicRef52488" href="/z/d/graphic/52488.html" rel="external">table 2</a>). Oro- or nasogastric tubes are available in two varieties, sump or feeding tubes, the placement of which are discussed separately (see  <a class="medical medical_review" href="/z/d/html/15070.html" rel="external">"Inpatient placement and management of nasogastric and nasoenteric tubes in adults"</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Sump tubes – Sump tubes are larger and stiffer than feeding tubes. They are generally inserted for gastric decompression but may be used for short periods to deliver EN when gastric decompression is no longer necessary (eg, up to two weeks). Concerns about longer-term use include nasal and esophageal erosion and sinusitis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Feeding tubes – Feeding tubes are of smaller diameter, are more flexible, and often require a stylet for insertion. Many feeding tubes cannot be used for gastric decompression because the soft walls tend to collapse when suction is applied.</p><p></p><p>On admission, some patients may already have a feeding tube in place for long-term feeding, which can be used in lieu of a placing a new feeding tube (provided they are functioning correctly). These include percutaneous endoscopic gastrostomy (PEG) tubes, percutaneous radiologic gastrostomy tubes, and surgical gastrostomy or jejunostomy tubes  (<a class="graphic graphic_figure graphicRef68626" href="/z/d/graphic/68626.html" rel="external">figure 1</a>). Further details regarding gastrostomy tubes are provided separately. (See  <a class="medical medical_review" href="/z/d/html/2568.html" rel="external">"Gastrostomy tubes: Uses, patient selection, and efficacy in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2552.html" rel="external">"Gastrostomy tubes: Complications and their management"</a>.)</p><p class="headingAnchor" id="H6"><span class="h2">Post-pyloric</span><span class="headingEndMark"> — </span>Most patients in the intensive care unit do not need post-pyloric feeding (ie, feeding tube tip in the duodenum or beyond the duodenal ligament of Treitz). Placement of post-pyloric feeding tubes is challenging in critically ill patients since they often require endoscopic or radiologic guidance.</p><p>Indications (eg, those with delayed gastric emptying or gastric outlet obstruction, failed aspiration precautions) and methods of placement (eg, endoscopic or image-guided) are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2583.html" rel="external">"Enteral feeding: Gastric versus post-pyloric"</a> and  <a class="medical medical_review" href="/z/d/html/2583.html" rel="external">"Enteral feeding: Gastric versus post-pyloric", section on 'Difficulty with placement and ease of displacement'</a>.)</p><p class="headingAnchor" id="H7"><span class="h1">FORMULATIONS</span><span class="headingEndMark"> — </span>Several EN formulations are commercially available for patients with critical illness. Common differences between formulations include osmolarity, caloric density, amount of protein per calorie, and electrolyte content [<a href="#rid3">3,4</a>]. Most are formulated to provide 100 percent of the recommended daily vitamin and mineral dose when a minimum of approximately 1000 kilocalories (kcal) or more are delivered per day. In addition, there may be differences related to whether they are intact or predigested, fiber or disease-specific nutrients are present or absent, and extra supplements are added (eg, <a class="drug drug_general" data-topicid="8747" href="/z/d/drug information/8747.html" rel="external">glutamine</a>).</p><p class="headingAnchor" id="H464403845"><span class="h2">Choosing a formulation</span><span class="headingEndMark"> — </span>No formulation has consistently demonstrated superiority over others. Choosing among formulations depends upon clinical factors including volume status and comorbidities (eg, kidney failure). Our approach is as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>Standard formula for most patients – For most critically ill patients, we use standard EN formulations since they provide sufficient nourishment if given with adequate total daily volume. (See <a class="local">'Standard'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Special formulas in select patients:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Volume restriction – For patients who require volume restriction, we use concentrated EN formulations (eg, 1.5 to 2 times more concentrated than standard formulations). However, when volume is adequately controlled using other means (eg, diuresis, dialysis), standard feedings are acceptable. (See <a class="local">'Concentrated formulas'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Kidney failure – For patients with kidney failure, we use a renal formula. The exception is patients on continuous kidney replacement therapy since continuous kidney replacement therapy is highly effective at removing electrolytes such as potassium and phosphate. Renal formulas are also typically more concentrated than standard formulas, which can be useful if the patient requires both fluid restriction and electrolyte control. (See <a class="local">'Renal'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Chylous accumulations – Patients with chylous accumulations (eg, thoracic duct leak, chylothorax, or chylous ascites), digestive defects (eg, short gut or malabsorptive syndromes that are unresponsive to supplementation with pancreatic enzymes), or intolerance of standard EN (eg, persistent diarrhea) may be prescribed predigested formulations. The selected predigested formulation depends upon the suspected underlying problem. (See <a class="local">'Predigested'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Others – We do not typically use diabetic or other disease-specific formulas (eg, hepatic, pulmonary) since none have demonstrated superiority to standard feeding products in patients who are critically ill.</p><p></p><p class="bulletIndent2">Diabetic formulas do not improve glycemic control in patients who are continuously fed but may have some benefit if patients are receiving bolus feeding [<a href="#rid5">5</a>]. However, these formulas are generally not useful in critically ill patients since the glycemic index is improved by slowing gastric emptying and not by changing the formulation. Management of enteral feeding in hospitalized patients with diabetes mellitus and glycemic control in critically ill patients are discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/1770.html" rel="external">"Management of diabetes mellitus in hospitalized patients", section on 'Enteral feedings'</a> and  <a class="medical medical_review" href="/z/d/html/1600.html" rel="external">"Glycemic control in critically ill adult and pediatric patients"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>No role for other supplements – We do not provide extra supplements (eg, <a class="drug drug_general" data-topicid="8747" href="/z/d/drug information/8747.html" rel="external">glutamine</a>) since these have not demonstrated any clear benefit. (See <a class="local">'Extra supplements of no proven benefit'</a> below.)</p><p></p><p class="headingAnchor" id="H8"><span class="h2">Standard</span><span class="headingEndMark"> — </span>Standard feeds are the most common EN formulation used in the intensive care unit (ICU). The following characteristics are typical of standard EN formulations:</p><p class="bulletIndent1"><span class="glyph">●</span>Isotonic to serum</p><p class="bulletIndent1"><span class="glyph">●</span>Caloric density of approximately 1 kcal/mL</p><p class="bulletIndent1"><span class="glyph">●</span>Lactose-free</p><p class="bulletIndent1"><span class="glyph">●</span>Intact (nonhydrolyzed) protein content of about 40 g/1000 mL (40 g/1000 kcal)</p><p class="bulletIndent1"><span class="glyph">●</span>Nonprotein calorie to nitrogen ratio of approximately 130:1</p><p class="bulletIndent1"><span class="glyph">●</span>Mixture of simple and complex carbohydrates</p><p class="bulletIndent1"><span class="glyph">●</span>Long-chain fatty acids (although some are now including medium-chain and omega-3 fatty acids)</p><p class="bulletIndent1"><span class="glyph">●</span>Essential vitamins, minerals, and micronutrients</p><p></p><p>The prescription of EN is tailored to the nutritional and fluid needs of each patient, the details of which are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1617.html" rel="external">"Nutrition support in intubated critically ill adult patients: Initial evaluation and prescription", section on 'Calculating calorie and protein requirements in adequately nourished patients'</a>.)</p><p class="headingAnchor" id="H713705223"><span class="h2">Formulations for special circumstances</span></p><p class="headingAnchor" id="H9"><span class="h3">Concentrated formulas</span><span class="headingEndMark"> — </span>Use of concentrated EN formulas is not routine. However, they may be appropriate in critically ill patients who require volume restriction (eg, volume overload not responsive to other means). (See <a class="local">'Choosing a formulation'</a> above.)</p><p>The standard composition of concentrated EN is similar to that of standard EN formulas, except that it is mildly hyperosmolar to serum and has a caloric density of 1.2, 1.5, or 2 kcal/mL. (See <a class="local">'Standard'</a> above.)</p><p>The routine use of concentrated EN does not appear to confer benefit when compared with standard formulations. In a randomized trial of 3957 medical ICU patients who were mechanically ventilated and receiving enteral feeds, despite providing an extra 600 kcal per day, patients receiving concentrated formula (1.5 kcal/mL) had similar mortality rates (27 versus 26 percent, respectively), ventilator-free days, duration of hospitalization, and infections compared with patients receiving a standard formula (1 kcal/mL) [<a href="#rid6">6</a>].</p><p>The hyperosmolality of concentrated EN was thought to predispose patients to diarrhea or symptoms similar to dumping syndrome. However, adult formulations rarely exceed approximately 750 milliosmoles/L and are rarely the primary cause of diarrhea, if infused slowly. However, concentrated EN is less likely to be tolerated if it is delivered rapidly in feeding tubes placed beyond the pylorus [<a href="#rid7">7</a>]. Dumping syndrome is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/89634.html" rel="external">"Postgastrectomy complications"</a>.)</p><p class="headingAnchor" id="H2088494083"><span class="h3">Renal</span><span class="headingEndMark"> — </span>Renal formulas may be helpful in managing patients who require fluid and/or electrolyte restriction, such as patients with acute kidney failure complicated by fluid overload, hyperkalemia, and/or hyperphosphatemia, or those on hemodialysis with difficulties managing electrolytes and volume.</p><p>Renal formulas are more concentrated than standard formulas with a caloric density of 1.8 or 2 kcal/mL, are hyperosmolar relative to serum (approximately 750 milliosmoles/L), and contain a slightly higher protein content (44 g/1000 kcal) but are otherwise similar. (See <a class="local">'Standard'</a> above.)</p><p class="headingAnchor" id="H10"><span class="h3">Predigested</span><span class="headingEndMark"> — </span>Predigested formulas (previously called chemically defined, semi-elemental, or elemental formula) contain peptides as opposed to intact protein. Predigested EN is not routinely administered as an initial tube feed in critically ill patients [<a href="#rid1">1</a>] but has been proposed as potentially beneficial in patients with specific digestive needs (eg, malabsorption due to mucosal disease), albeit without supporting evidence. (See <a class="local">'Choosing a formulation'</a> above.)</p><p>Predigested EN usually has a caloric density of 1 or 1.5 kcal/mL. It differs from standard EN in that the protein is hydrolyzed to short-chain peptides and the carbohydrates are in a less complex form. The total amount of fat may be decreased, with an increased proportion of medium-chain triglycerides, or the triglycerides altered or structured to contain various mixes of fatty acids. Essential vitamins, minerals, and micronutrients are similar to standard formulations.</p><p>Patients who tolerate predigested EN can sometimes be transitioned to standard EN later, especially if the underlying problem has resolved.</p><p>In critically ill patients, studies of predigested feed products have not demonstrated differences in mortality, infectious complications, or the incidence of diarrhea when compared with standard EN [<a href="#rid8">8,9</a>].</p><p class="headingAnchor" id="H12"><span class="h1">COMPOSITION</span><span class="headingEndMark"> — </span>The daily volume of feed is first based upon estimated calorie needs (ie, carbohydrate and fat content). Then the appropriate formula that best delivers the estimated protein needs is chosen. If protein needs cannot be acceptably met with available feeding products, protein supplements may be administered. Calculating calorie and protein needs is described separately. (See  <a class="medical medical_review" href="/z/d/html/1617.html" rel="external">"Nutrition support in intubated critically ill adult patients: Initial evaluation and prescription", section on 'Calculating calorie and protein requirements in adequately nourished patients'</a>.)</p><p class="headingAnchor" id="H13"><span class="h2">Carbohydrate/fat</span><span class="headingEndMark"> — </span>Standard EN delivers 49 to 53 percent of calories as carbohydrates and 29 to 30 percent of calories as fat.</p><p>Low carbohydrate/high fat formulations and high carbohydrate/low fat formulations are available. Neither is recommended for routine feeding, nor do they have evidence for efficacy. However, they have been proposed for use in patients who are obese with critical illness (low carbohydrate/high fat [<a href="#rid10">10-14</a>]) or patients with chyle leak or maldigestion (high carbohydrate/low fat).</p><p class="headingAnchor" id="H14"><span class="h2">Protein</span><span class="headingEndMark"> — </span>Standard EN delivers an intact (nonhydrolyzed) protein content of about 40 g/1000 kilocalories (kcal) while most "high nitrogen" and renal EN formulas deliver a protein content of 44 g/1000 kcal. High protein feeds contain 60 to 65 g/1000 kcal.</p><p class="headingAnchor" id="H2815204373"><span class="h2">Other (vitamins, minerals, trace elements, fiber)</span><span class="headingEndMark"> — </span>Most formulations contain the daily recommended allowances of essential vitamins, minerals, and trace elements. (See  <a class="medical medical_review" href="/z/d/html/5368.html" rel="external">"Vitamin intake and disease prevention", section on 'Vitamin deficiency and definitions of adequate intake'</a>.)</p><p>Some formulas also contain variable amounts of dietary fiber; however, these are infrequently used unless the patient has EN-related diarrhea. (See <a class="local">'Diarrhea'</a> below.)</p><p class="headingAnchor" id="H567851518"><span class="h2">Extra supplements of no proven benefit</span><span class="headingEndMark"> — </span>The following nutrients and additives, provided in amounts in excess of the daily recommended requirements, have been studied in critically ill patients. However, the available evidence has not demonstrated a clear benefit of these supplements, and we therefore suggest <strong>against</strong> using them.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Omega-3 fatty acids</strong> – Omega-3 fatty acids have anti-inflammatory properties [<a href="#rid15">15</a>] and have been studied in patients with sepsis [<a href="#rid16">16,17</a>], patients with acute respiratory distress syndrome [<a href="#rid18">18-22</a>], and patients undergoing cardiac surgery [<a href="#rid23">23</a>]. While early trials suggested a possible benefit, subsequent trials and meta-analyses failed to detect a meaningful mortality benefit from omega-3 fatty acids with or without antioxidants [<a href="#rid17">17,22,23</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Glutamine</strong> <strong>and its precursor, ornithine ketoglutarate (OKG)</strong> – Glutamine is necessary for nucleotide synthesis and is rapidly depleted in catabolic states. In a meta-analysis of 36 randomized trials involving 3454 critically ill patients randomly assigned to <a class="drug drug_general" data-topicid="8747" href="/z/d/drug information/8747.html" rel="external">glutamine</a> supplementation or control, hospital mortality was lower in the glutamine group (17.5 versus 19.7 percent); however, the difference was not statistically significant (relative risk [RR] 0.89, 95% CI 0.78-1.02) [<a href="#rid24">24</a>]. Glutamine supplementation modestly reduced infectious complications (32 versus 40 percent; RR 0.79, 95% CI 0.71-0.87). However, many of the trials included in the meta-analysis had important limitations (lack of blinding, incomplete or selective reporting) and the meta-analysis found evidence of publication bias. Thus, the certainty of these findings is low.</p><p></p><p class="bulletIndent1">OKG is a <a class="drug drug_general" data-topicid="8747" href="/z/d/drug information/8747.html" rel="external">glutamine</a> precursor that restores pools of glutamine in catabolic patients. A meta-analysis of three randomized trials involving 163 burn patients found that mortality was similar in patients who did and those who did not receive OKG supplementation (10 percent in both groups) [<a href="#rid25">25</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8883" href="/z/d/drug information/8883.html" rel="external">Arginine</a> – Arginine is required for normal immune function and healing and has important roles in nitrogen and ammonia metabolism and the generation of nitric oxide. In a meta-analysis of 14 trials involving 1624 critically ill patients, mortality was similar in patients who did and those who did not receive arginine supplementation (24 versus 23 percent; RR 1.05, 95% CI 0.79-1.38) [<a href="#rid26">26</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Beta-hydroxy-beta-methylbutyrate (HMB)</strong> – HMB is a metabolite of the essential amino acid leucine that has anabolic effects on protein metabolism. Supplementation with HMB has been proposed as a possible intervention for critically ill patients to prevent muscle wasting. Data on use of HMB in this setting are very limited. Based on the available clinical trial data, HMB does not appear to reduce muscle wasting in critically ill patients [<a href="#rid27">27,28</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prebiotics and probiotics</strong> – Pr<strong>e</strong>biotics are nondigestible carbohydrates (fiber) that promote the growth of beneficial bacteria and hinder the growth of harmful bacteria in the bowel. Pr<strong>o</strong>biotics (eg, <a class="drug drug_general" data-topicid="9541" href="/z/d/drug information/9541.html" rel="external">Lactobacillus</a> species) are living microorganisms that are purported to provide a health benefit to the host when ingested.</p><p></p><p class="bulletIndent1">In a meta-analysis of 49 trials (27 investigating probiotics; 22 investigating combined prebiotic/probiotic supplements) that involved 6746 critically ill patients, mortality rates were similar in patients who did and those who did not receive probiotics or prebiotics (21 versus 23 percent, respectively; RR 0.93, 95% CI 0.85-1.02) [<a href="#rid29">29</a>]. Probiotics appeared to lower the incidence of diarrhea and infectious complications when all trials reporting this outcome were analyzed (29 trials; 5455 patients); however, when analysis was restricted to high-quality trials, there was no apparent reduction in either outcome [<a href="#rid29">29</a>].</p><p></p><p class="bulletIndent1">The role of probiotics in the management of patients with diarrheal illnesses (eg, <em>Clostridioides difficile</em> infection, antibiotic-associated diarrhea) is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2698.html" rel="external">"<i>Clostridioides difficile</i> infection in adults: Treatment and prevention", section on 'Alternative therapies'</a> and  <a class="medical medical_review" href="/z/d/html/2603.html" rel="external">"Probiotics for gastrointestinal diseases", section on 'Diarrheal illnesses'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Extra fiber</strong> – Standard formulations are not routinely supplemented with extra fiber since the available evidence suggests that it does not prevent diarrhea [<a href="#rid30">30,31</a>]. Fiber supplementation is an option for patients with EN-related diarrhea, as discussed below. (See <a class="local">'Diarrhea'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antioxidant vitamins and trace elements</strong> – Antioxidant nutrients include <a class="drug drug_general" data-topicid="9884" href="/z/d/drug information/9884.html" rel="external">selenium</a>, copper, zinc, <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a>, <a class="drug drug_general" data-topicid="9776" href="/z/d/drug information/9776.html" rel="external">vitamin C</a>, <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">vitamin E</a>, and <a class="drug drug_general" data-topicid="9317" href="/z/d/drug information/9317.html" rel="external">N-acetylcysteine</a>. These can be given as single additives or in combination. The available clinical trial data do not support the routine use of antioxidant supplements above the recommended daily allowance [<a href="#rid32">32-34</a>]. In a network meta-analysis that included 36 randomized trials (4885 critically ill patients) and compared various antioxidant micronutrient supplements (alone or in combination), none appeared to be more effective than placebo for reducing all-cause mortality [<a href="#rid34">34</a>].</p><p></p><p class="bulletIndent1">Additional data on <a class="drug drug_general" data-topicid="9776" href="/z/d/drug information/9776.html" rel="external">vitamin C</a> supplementation in patients with sepsis are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1631.html" rel="external">"Investigational and ineffective pharmacologic therapies for sepsis", section on 'Vitamin C'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Combined immune modulator supplements</strong> – In a randomized trial evaluating enteral supplementation with a combination of some of the additives discussed above (<a class="drug drug_general" data-topicid="8747" href="/z/d/drug information/8747.html" rel="external">glutamine</a> plus omega-3 fatty acid plus antioxidant vitamins and trace elements [vitamins C and E, <a class="drug drug_general" data-topicid="9884" href="/z/d/drug information/9884.html" rel="external">selenium</a>, and zinc]), hospital mortality was similar in patients who did and those who did not receive the supplement (25 versus 22 percent, respectively) [<a href="#rid35">35</a>]. Rates of infectious complications were also similar in both groups (53 versus 52 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vitamin D</strong> – Levels of vitamin D, which is protein bound, drop in critical illness, much in the same way a decrease in albumin lowers calcium levels. Despite a correlation between low vitamin D levels and intensive care unit mortality, vitamin D supplementation has no clinical impact [<a href="#rid36">36,37</a>].</p><p></p><p class="headingAnchor" id="H4081762468"><span class="h1">DELIVERY STRATEGY</span><span class="headingEndMark"> — </span>The daily amount of EN is tailored to the nutritional and fluid needs of each patient. Unless fluid overload is an issue, we generally choose a nonconcentrated standard formulation. (See <a class="local">'Choosing a formulation'</a> above and <a class="local">'Standard'</a> above.)</p><p class="headingAnchor" id="H23"><span class="h2">Continuous versus bolus</span><span class="headingEndMark"> — </span>EN is typically administered as a continuous infusion (over a 24-hour period) or cycled infusion (over 12 hours in a 24-hour period). While we prefer infusions to decrease the risk of vomiting, reflux, and aspiration, data comparing infusions with bolus feeding have not shown any differences in mortality, infections, or intensive care unit length of stay [<a href="#rid38">38-40</a>].</p><p class="headingAnchor" id="H24"><span class="h2">Delivery volume and rate</span><span class="headingEndMark"> — </span>Our approach is the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nutritional goal</strong> – Calculating the goal target rate involves calculating the dosing weight as well as the calorie and protein target goal. Details regarding the calculation of such goals are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1617.html" rel="external">"Nutrition support in intubated critically ill adult patients: Initial evaluation and prescription", section on 'Calculating calorie and protein requirements in adequately nourished patients'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Volume/rate</strong> – The volume and rate are calculated based upon the caloric needs of the patient and the calorie concentration of the formulation used. For most patients, we initiate EN at an hourly rate that is less than the full desired target (eg, 30 to 50 percent of the ultimate target goal), then slowly increase the rate over three to seven days until the full target is reached. This approach should result in the patient reaching a stable target rate within a reasonable period of time, provided that the EN is not repeatedly paused. Support for this approach is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1617.html" rel="external">"Nutrition support in intubated critically ill adult patients: Initial evaluation and prescription", section on 'Calculating calorie and protein requirements in adequately nourished patients'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Example</strong> – For a 60 kg patient, assuming caloric and protein needs are 25 kilocalories (kcal)/kg and 1.5 g/kg per day, respectively:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Target caloric intake = 25 kcal/kg per day x 60 kg = 1500 kcal per day</p><p class="bulletIndent2"><span class="glyph">•</span>Target protein intake = 1.5 g/kg per day x 60 kg = 90 g protein per day</p><p></p><p class="bulletIndent1">The best match for this patient would be a high-protein formula with a caloric density of 1 kcal/mL and a protein concentration of 60 g/L.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The total volume required to meet caloric needs = 1500 kcal per day ÷ 1 kcal/mL = 1500 mL per day</p><p class="bulletIndent2"><span class="glyph">•</span>Total protein from this volume = 1500 mL x 60 g/1000 mL = 90 g of protein per day</p><p class="bulletIndent2"><span class="glyph">•</span>The target rate for full continuous feeds = 1500 mL ÷ 24 hours = 62.5 mL/hour (rounding up to 65 mL/hour is reasonable)</p><p class="bulletIndent2"><span class="glyph">•</span>An appropriate starting rate = 30 to 50% x 65 mL/hour (which is approximately 20 to 30 mL/hour)</p><p></p><p class="headingAnchor" id="H88054915"><span class="h2">Water supplementation</span><span class="headingEndMark"> — </span>Most patients require supplementation of water (eg, 100 mL every six to eight hours) in addition to the EN formulation. All feeding tubes should also have periodic water flushes to minimize clogging. Only water should be used for flushing. Acidic fluids, such as soda or fruit juice, should be specifically avoided as they increase the risk of feeding tube blockage [<a href="#rid41">41</a>]. (See <a class="local">'Fluid/water/electrolyte disturbance'</a> below.)</p><p class="headingAnchor" id="H25"><span class="h1">MONITORING AND MANAGEMENT OF COMPLICATIONS</span><span class="headingEndMark"> — </span>For patients on enteral feeding, we monitor daily for complications including the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Feeding intolerance (see <a class="local">'Feeding intolerance'</a> below)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Aspiration (see <a class="local">'Aspiration'</a> below)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Gut dysfunction (eg, diarrhea, constipation) (see <a class="local">'Diarrhea'</a> below and <a class="local">'Constipation'</a> below)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fluid and electrolyte imbalance (eg, extremity or pulmonary edema, hypo-/hyperkalemia, hypo-/hyperphosphatemia) (see <a class="local">'Fluid/water/electrolyte disturbance'</a> below)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Refeeding syndrome (see <a class="local">'Refeeding syndrome'</a> below)</p><p></p><p class="headingAnchor" id="H1068315249"><span class="h2">Feeding intolerance</span><span class="headingEndMark"> — </span>Once EN is initiated, patients are observed at the bedside, most often by nursing staff, for signs of intolerance including gastric distention, abdominal discomfort, diarrhea, nausea, reflux of feeds, and vomiting. There is no optimal approach to managing intolerance. General principles include measuring gastric residual volume (GRV), addressing the etiology, and resuming feeds once the cause has been treated.</p><p class="headingAnchor" id="H1255168420"><span class="h3">Measure gastric residual volume</span><span class="headingEndMark"> — </span>We do not routinely measure GRV as a way to assess tolerance of feeding to prevent aspiration. We only measure GRV in patients exhibiting signs of intolerance and if the GRV is &gt;500 mL, we hold feeding. The cause for elevated GRV should be investigated and should be addressed prior to attempting to feed again (eg, ileus, delayed gastric emptying). Although it is unclear how long feeds should be held, we resume feeds as quickly as is feasible to reduce the risk of malnutrition from delayed feeding. Assessment of intolerance of feeding is discussed below. (See <a class="local">'Address the etiology'</a> below.)</p><p>Our approach is based upon studies that have shown poor correlation between GRV and pneumonia risk and that the practice of holding feeds for high GRV (eg, &gt;250 mL) is associated with a decrease in calorie delivery [<a href="#rid42">42-45</a>]. In an unblinded trial, 449 intensive care unit (ICU) patients were randomly assigned to monitoring of GRV every six hours, with adjustment of feeding rate for residuals over 250 mL or only monitoring when enteral feeds were adjusted only when patients experienced vomiting or regurgitation [<a href="#rid45">45</a>]. While there were almost twice as many vomiting episodes in the group without monitoring, there was a similar rate of ventilator-associated pneumonia in both groups (16 percent each). The proportion of patients who received 100 percent of their calories was greater in the group that did not undergo routine GRV assessment. Other ICU outcomes were similar, such as duration of ICU-acquired infection, mechanical ventilation duration, hospital length of stay, and short- and long-term mortality.</p><p class="headingAnchor" id="H977335332"><span class="h3">Address the etiology</span><span class="headingEndMark"> — </span>In most cases, feeding intolerance is due to ileus or constipation. Rarely is it due to mechanical obstruction, delayed gastric emptying syndrome, ischemic gut, Ogilvie syndrome, or organic issues (eg, intrabdominal leak, abscess, <em>Clostridioides difficile</em> infection, or retroperitoneal bleed).</p><p>We typically obtain an abdominal radiograph. If the radiograph and clinical examination are not helpful, we obtain abdominal computed tomography (preferably with contrast) or (less commonly) gastroscopy to look for more serious pathology.</p><p>We correct the suspected etiology and resume feeding. In many cases, treating constipation and/or ileus with laxatives and a motility agent resolves intolerance. Rarely, post-pyloric feeding or jejunal feeding is needed. (See <a class="local">'Constipation'</a> below and  <a class="medical medical_review" href="/z/d/html/2583.html" rel="external">"Enteral feeding: Gastric versus post-pyloric"</a> and <a class="local">'Post-pyloric'</a> above.)</p><p class="headingAnchor" id="H4010705"><span class="h2">Aspiration</span><span class="headingEndMark"> — </span>Patients receiving EN have an increased incidence of aspiration. However, it is not clear whether most aspiration events, such as microaspiration, cause harmful clinical outcomes (eg, aspiration of a large volume causing hypoxia or pneumonitis).</p><p>In support of this, nutrition support early in the course of critical illness has been associated with a decrease in the rate of infections including nosocomial pneumonia. In addition, microaspiration during sleep occurs in up to 50 percent of individuals in the general population and without obvious harm [<a href="#rid46">46</a>]. Numerous studies have also confirmed that aspiration of oropharyngeal secretions is the main cause of nosocomial pneumonia in the ventilated patient and have failed to demonstrate that aspiration of gastric contents is a significant cause. Data that support the benefit of early feeding and risk factors for ventilator-associated pneumonia are described separately. (See  <a class="medical medical_review" href="/z/d/html/6995.html" rel="external">"Risk factors and prevention of hospital-acquired and ventilator-associated pneumonia in adults"</a>.)</p><p class="headingAnchor" id="H2047484805"><span class="h3">Prevention</span><span class="headingEndMark"> — </span>Backrest (also known as head of the bed) elevation and the selective measurement of GRV (in patients who are intolerant of EN) are considered preventive measures for aspiration. Other measures such as post-pyloric feeding, percutaneous or surgical feeding devices, or motility agents are not routine but may be considered in select cases (eg, high risk of aspiration or long-term need for EN); however, supportive efficacy data are lacking.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Backrest elevation</strong> – We advocate backrest elevation at 30 to 45 degrees during enteral feeding as a maneuver to prevent aspiration. When 30 to 45 degrees is not feasible, we elevate the backrest as much as possible and limit laying the patient flat as much as is possible.</p><p></p><p class="bulletIndent1">Limited data support this practice. At best, backrest elevation likely prevents aspiration [<a href="#rid43">43</a>], but may not reduce the incidence of clinically significant pneumonia [<a href="#rid47">47</a>]. As an example, a meta-analysis of three randomized trials (337 patients) [<a href="#rid48">48-50</a>] failed to find a reduction in the rate of pneumonia [<a href="#rid47">47</a>] and there did not appear to be an impact on issues such as decubitus ulcers or mortality.</p><p></p><p class="bulletIndent1">Despite the recommendations, adherence is poor and maintenance of the optimal semirecumbent position is challenging. In one multicenter study, the average amount of backrest elevation was approximately 20 degrees, which did not confer any clinical benefits [<a href="#rid49">49</a>]. In another study [<a href="#rid51">51</a>], which set 30 degrees as the goal, mean compliance was only 53.6 percent.</p><p></p><p class="bulletIndent1">There is no contraindication to EN when patients are ventilated in the prone position. Further details that discuss feeding in the prone position are provided separately. (See  <a class="medical medical_review" href="/z/d/html/1630.html" rel="external">"Prone ventilation for adult patients with acute respiratory distress syndrome", section on 'Feeding'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Measuring GRV in select patients</strong> – We measure GRV in select patients exhibiting signs or symptoms of intolerance. Data to support this practice are described above. (See <a class="local">'Measure gastric residual volume'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other strategies (not routine)</strong> – We do not routinely perform post-pyloric feeding, insert percutaneous or surgical feeding devices, or administer motility agents (eg, <a class="drug drug_general" data-topicid="9642" href="/z/d/drug information/9642.html" rel="external">metoclopramide</a>, <a class="drug drug_general" data-topicid="9418" href="/z/d/drug information/9418.html" rel="external">erythromycin</a>) to prevent aspiration in the critically ill since data show little to no benefit. However, for patients at high risk of aspiration (eg, significant reflux, poor gastric tolerance to enteral feedings) or for those with long-term needs for EN, some of these strategies may be used.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Post-pyloric feeding</strong> – Most data report little to no benefit from the routine placement of feeding tubes to promote post-pyloric feeding [<a href="#rid52">52,53</a>]. While one meta-analysis found a reduction in the incidence of pneumonia [<a href="#rid54">54</a>], this benefit disappeared after one controversial study was removed from the analysis [<a href="#rid1">1,2</a>]. We only target post-pyloric feeding in those with indications, which are discussed in a separate topic review. (See  <a class="medical medical_review" href="/z/d/html/2583.html" rel="external">"Enteral feeding: Gastric versus post-pyloric"</a> and  <a class="medical medical_review" href="/z/d/html/2583.html" rel="external">"Enteral feeding: Gastric versus post-pyloric", section on 'Difficulty with placement and ease of displacement'</a> and <a class="local">'Post-pyloric'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Percutaneous or surgical feeding</strong> – We only place percutaneous or surgical feeding tubes in patients in whom there is an anticipated long-term need for enteral feeding. Surgical feeding tubes may be considered earlier than usual if there is a contraindication to nasal tubes and long-term feeding is anticipated, although <a class="drug drug_general" data-topicid="10307" href="/z/d/drug information/10307.html" rel="external">parenteral nutrition</a> is also an option in this population.</p><p></p><p class="bulletIndent2">Whether percutaneous or surgical feeding devices reduce aspiration and pneumonia is unclear. Some data suggest that long-term complications in non-critically ill patients with swallowing problems are no different when gastrostomy feeding is compared with nasogastric or nasoenteric feeding [<a href="#rid55">55</a>] while other data suggest a higher rate of adverse effects when gastrostomy feeding is compared with nasal feeding [<a href="#rid56">56</a>].</p><p></p><p class="bulletIndent2">There is a growing practice of simultaneous insertion of percutaneous endoscopic gastrostomy (PEG) tubes at the same time as tracheostomy [<a href="#rid57">57</a>]. While this practice may be convenient, the benefit is unproven and may be driven by the need to reduce length of acute hospital stay and skilled nursing home policies [<a href="#rid58">58,59</a>]. For example, one study reported that the rate of acceptance of patients with temporary nasal tubes was significantly lower in New York City compared with the national average (18 versus 62 percent) [<a href="#rid60">60</a>]. In keeping with this observation, it has been reported that gastrostomies are being inserted earlier during hospitalization and in sicker patients [<a href="#rid57">57</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Motility agents</strong> – We only administer motility agents to patients who are at high risk of aspiration (eg, patients with known reflux or aspiration) or who have poor gastric tolerance to enteral feedings. A meta-analysis of four randomized trials (494 patients) found that routinely administering <a class="drug drug_general" data-topicid="9642" href="/z/d/drug information/9642.html" rel="external">metoclopramide</a> and <a class="drug drug_general" data-topicid="9418" href="/z/d/drug information/9418.html" rel="external">erythromycin</a> did not change mortality or the incidence of nosocomial pneumonia compared with placebo or no intervention [<a href="#rid61">61-63</a>].</p><p></p><p class="headingAnchor" id="H3470686974"><span class="h3">Management</span><span class="headingEndMark"> — </span>Management of aspiration pneumonia is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/7024.html" rel="external">"Aspiration pneumonia in adults"</a> and  <a class="medical medical_review" href="/z/d/html/6993.html" rel="external">"Treatment of hospital-acquired and ventilator-associated pneumonia in adults"</a>.)</p><p class="headingAnchor" id="H32"><span class="h2">Diarrhea</span><span class="headingEndMark"> — </span>Diarrhea is estimated to occur in approximately 15 to 18 percent of critically ill patients who receive EN, compared with only 6 percent of patients who do not receive EN [<a href="#rid64">64,65</a>]. This is likely to be higher in patients with greater severity of illness and longer length of stay. The precise mechanism is unknown, but proposed mechanisms include alteration of intestinal transit or the intestinal microflora and concomitant administration of medications that can cause diarrhea (eg, antibiotics, proton pump inhibitors). Enteral electrolyte supplementation and medications delivered in <a class="drug drug_general" data-topicid="9940" href="/z/d/drug information/9940.html" rel="external">sorbitol</a> suspension are also likely to cause diarrhea. Concentrated feedings are only mildly hypertonic and are unlikely to induce significant diarrhea. (See <a class="local">'Concentrated formulas'</a> above.)</p><p>We evaluate suspected EN-related diarrhea by excluding other etiologies, such as antibiotic- or <em>Clostridioides difficile</em>-related diarrhea. EN does not need to be interrupted for diarrhea and should be continued while the etiology is being investigated. If diarrhea persists and enteral feeding is still suspected as the etiology, we switch to a mixed fiber-containing EN formula [<a href="#rid66">66</a>]. However, we use fiber with caution in patients with impaired peristalsis (eg, patients receiving vasopressors) due to the risk of precipitating a fiber bezoar. (See <a class="local">'Constipation'</a> below and <a class="local">'Fiber bezoar'</a> below.)</p><p>Fibers contained in tube feeding products vary in their composition and are usually a mixture that does not clog feeding tubes. When supplementing EN with extra fiber, we prefer highly soluble fibers where the effect is primarily osmotic. This includes guar gum, <a class="drug drug_general" data-topicid="16098" href="/z/d/drug information/16098.html" rel="external">wheat dextrin</a>, inulin, or fructooligosaccharides, which do not gelatinize when dissolved and do not block the feeding tube. We do not use less soluble or gelatinous fibers, such as that from <a class="drug drug_general" data-topicid="9834" href="/z/d/drug information/9834.html" rel="external">psyllium</a>, which can help solidify stool but can block the feeding tube. If diarrhea persists in patients receiving highly soluble fiber supplementation, we discontinue fiber supplementation and search for other causes of diarrhea.</p><p>Limited data support the use of highly soluble fibers in those with diarrhea. Three [<a href="#rid67">67-69</a>] of five randomized trials [<a href="#rid30">30,68</a>] in critically ill patients showed a reduction in diarrhea using fiber supplementation. None showed changes in any other outcome. It is theorized that their fermentation to short-chain fats improves colonic biology. But we theorize that because they do not gel, they may be equally likely to make diarrhea worse due to their osmotic effect. Thus, their use should be on a trial basis only. The evaluation and management of diarrhea in non-critically ill patients are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2717.html" rel="external">"Approach to the adult with acute diarrhea in resource-abundant settings"</a> and  <a class="medical medical_review" href="/z/d/html/13954.html" rel="external">"Approach to the adult with acute diarrhea in resource-limited settings"</a>.)</p><p class="headingAnchor" id="H35"><span class="h2">Constipation</span><span class="headingEndMark"> — </span>Constipation can cause impaction, bowel distention, perforation, and death if not treated early, although these sequelae are very rare.</p><p>Constipation is a well-known consequence of critical illness despite prophylactic laxatives, which are often prescribed in this population. Fecal impaction is less common. We maintain adequate hydration (an increase in free water may be needed) and prescribe laxatives (eg, polyethylene glycol, magnesium containing laxatives) for the treatment of constipation. If these measures fail, concentrated nonabsorbable sugar alcohols (eg, <a class="drug drug_general" data-topicid="9940" href="/z/d/drug information/9940.html" rel="external">sorbitol</a>, <a class="drug drug_general" data-topicid="9543" href="/z/d/drug information/9543.html" rel="external">lactulose</a>) or enemas may be required. While many ICU patients receive <a class="drug drug_general" data-topicid="9382" href="/z/d/drug information/9382.html" rel="external">docusate</a> and/or <a class="drug drug_general" data-topicid="10260" href="/z/d/drug information/10260.html" rel="external">senna</a> prophylactically, their role in the treatment of constipation is limited [<a href="#rid70">70</a>].</p><p>Evaluation and management of constipation is described separately. (See  <a class="medical medical_review" href="/z/d/html/2637.html" rel="external">"Etiology and evaluation of chronic constipation in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2636.html" rel="external">"Management of chronic constipation in adults"</a>.)</p><p class="headingAnchor" id="H1324171607"><span class="h2">Fluid/water/electrolyte disturbance</span><span class="headingEndMark"> — </span>All feeding products consist of only 70 to 80 percent water. As a result, they are generally unable to meet patients' normal water requirements (EN providing 25 kilocalories (kcal)/kg with a 1 kcal/mL formula provides an average of only 20 mL/kg of water). This may be beneficial for patients who require fluid restriction, but most patients require another source of water. Feeding tubes must be flushed regularly with water to avoid clogging; flushing can also occur with medication, and patients in ICU are rarely without sources of intravenous fluids. Such supplements may suffice, but volume status and sodium level should be monitored daily until the patient is stable on their feeding regimen.</p><p>Adverse metabolic consequences of EN include hyperglycemia, micronutrient deficiencies, and electrolyte abnormalities (including hyper-/hypokalemia and hyper-/hypophosphatemia). We perform daily electrolyte monitoring until stable. Electrolyte abnormalities should be promptly treated. Glucose control in critically ill patients is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1600.html" rel="external">"Glycemic control in critically ill adult and pediatric patients"</a>.)</p><p class="headingAnchor" id="H3479237328"><span class="h2">Refeeding syndrome</span><span class="headingEndMark"> — </span>Refeeding syndrome is a potentially fatal condition resulting from rapid changes in fluids and electrolytes when patients who have been malnourished are given oral, enteral, or parenteral feedings [<a href="#rid71">71</a>]. It is defined primarily by the development of hypophosphatemia, hypokalemia, and hypomagnesemia. Diagnosis, prevention, and management of refeeding syndrome are described in greater detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/15778.html" rel="external">"Anorexia nervosa in adults and adolescents: The refeeding syndrome"</a>.)</p><p class="headingAnchor" id="H787481744"><span class="h2">Feeding tube complications</span><span class="headingEndMark"> — </span>Complications can be due to the feeding tube itself.</p><p>Insertion or dislocation of an orogastric, nasogastric, or nasoenteric tube can cause mechanical complications, such as insertion into the lung or esophageal perforation. Placement and management of nasogastric and nasoenteric tubes are described separately. (See  <a class="medical medical_review" href="/z/d/html/15070.html" rel="external">"Inpatient placement and management of nasogastric and nasoenteric tubes in adults", section on 'Complications'</a>.)</p><p>Patients who receive enteral feedings through a gastrostomy tube are also at risk for complications related to the tube (eg, bleeding following insertion, tube dysfunction, wound infection, or ulceration). Further details regarding the management of gastrostomy complications are described separately. (See  <a class="medical medical_review" href="/z/d/html/2552.html" rel="external">"Gastrostomy tubes: Complications and their management"</a>.)</p><p class="headingAnchor" id="H1326713753"><span class="h2">Fiber bezoar</span><span class="headingEndMark"> — </span>Development of a fiber bezoar is a rare complication that can occur among patients receiving enteral feedings with extra fiber. Fiber bezoars can cause impaction, bowel distention, perforation, and death if not treated early, although these sequelae are very rare. Fiber bezoars may be more prevalent when peristalsis is impaired, such as in patients on vasopressors [<a href="#rid1">1,72,73</a>]. The risk factors for bezoars are poorly understood, and the incidence is rare. The diagnosis and management of gastric bezoars are provided separately. (See  <a class="medical medical_review" href="/z/d/html/2535.html" rel="external">"Gastric bezoars"</a>.)</p><p class="headingAnchor" id="H1809040755"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/111340.html" rel="external">"Society guideline links: Nutrition support (parenteral and enteral nutrition) in adults"</a>.)</p><p class="headingAnchor" id="H37"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Delivery route</strong> – Enteral nutrition (EN) refers to the provision of calories, protein, electrolytes, vitamins, minerals, trace elements, and fluids via an intestinal route. EN is most commonly delivered to the stomach via an orogastric or nasogastric tube  (<a class="graphic graphic_table graphicRef52488" href="/z/d/graphic/52488.html" rel="external">table 2</a>). Post-pyloric feeding is typically reserved for those who are at high risk of aspiration (eg, gastric outlet obstruction) or fail standard aspiration precautions. (See <a class="local">'Route of delivery'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Choosing a formulation</strong> – Several formulations are available. Choosing one depends upon the presence of specific comorbidities. Our approach is as follows (see <a class="local">'Formulations'</a> above and <a class="local">'Choosing a formulation'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Standard enteral formulas are appropriate for most critically ill patients in whom EN is prescribed. Standard formulas provide sufficient nourishment if an adequate daily volume is given. Standard EN comprises 49 to 53 percent of calories as carbohydrate and 29 to 30 percent of calories as fat, approximately 40 g of protein per 1000 kilocalories, and the daily recommended allowances of essential vitamins, minerals, and micronutrients. (See <a class="local">'Choosing a formulation'</a> above and <a class="local">'Standard'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Special formulations may be required in certain circumstances. Examples include (see <a class="local">'Formulations for special circumstances'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Patients who require volume restriction may require concentrated EN (eg, 1.5 to 2 times more concentrated than standard formulations). (See <a class="local">'Concentrated formulas'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Patients with kidney failure (except for those on continuous kidney replacement therapy) may require a special renal formula. (See <a class="local">'Renal'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Patients with chylous accumulations, digestive defects, or intolerance of standard EN may require predigested formulations. (See <a class="local">'Predigested'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For most patients, we suggest <strong>not</strong> routinely supplementing EN with omega-3 fatty acids, <a class="drug drug_general" data-topicid="8747" href="/z/d/drug information/8747.html" rel="external">glutamine</a>, ornithine ketoglutarate, <a class="drug drug_general" data-topicid="8883" href="/z/d/drug information/8883.html" rel="external">arginine</a>, beta-hydroxy-beta-methylbutyrate, prebiotics, probiotics, fiber, or antioxidant vitamins and trace elements (eg, vitamins A, C, or E; <a class="drug drug_general" data-topicid="9884" href="/z/d/drug information/9884.html" rel="external">selenium</a>; copper; zinc) in excess of daily recommended requirements (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). Clinical trial evidence on use of these supplements in patients with critical illness is either limited or has not demonstrated any meaningful clinical benefit. (See <a class="local">'Extra supplements of no proven benefit'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initiation and delivery</strong> – EN is typically administered as a continuous infusion (over a 24-hour period) or cycled infusion (over 12 hours in a 24-hour period). In most patients, we initiate feeds at a rate that is 30 to 50 percent of the full target goal. Feeds are then increased over three to seven days until the full target is reached. Water supplementation is typically used to avoid clogging of the feeding tube and may also be needed to meet daily fluid requirements. (See <a class="local">'Delivery strategy'</a> above and  <a class="medical medical_review" href="/z/d/html/1617.html" rel="external">"Nutrition support in intubated critically ill adult patients: Initial evaluation and prescription", section on 'Calculating calorie and protein requirements in adequately nourished patients'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Feeding intolerance</strong> – Patients should be observed at the bedside for clinical signs of feeding intolerance, which include gastric distention, abdominal discomfort, diarrhea, nausea, reflux of feeds, and vomiting. In patients with clinical signs of intolerance, the gastric residual volume should be measured and if &gt;500 mL, feeds should be stopped. Once the etiology has been addressed, tube feed can be resumed. (See <a class="local">'Feeding intolerance'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Aspiration</strong> – Aspiration is common in mechanically ventilated patients. To prevent aspiration, backrest (head of the bed) elevation at 30 to 45 degrees during enteral feeding is common practice, although data to support it are limited and maintenance of positioning is challenging. Management of aspiration pneumonia is discussed separately. (See <a class="local">'Aspiration'</a> above and  <a class="medical medical_review" href="/z/d/html/7024.html" rel="external">"Aspiration pneumonia in adults"</a> and  <a class="medical medical_review" href="/z/d/html/6993.html" rel="external">"Treatment of hospital-acquired and ventilator-associated pneumonia in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other complications</strong> – We typically manage the following complications if they arise:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Diarrhea – EN does not need to be interrupted for diarrhea and should be continued while the etiology is being investigated (eg, antibiotic- or <em>Clostridioides difficile</em>-related diarrhea). If diarrhea persists and enteral feeding is suspected as the etiology, switching to a mixed fiber-containing EN formula may reduce diarrhea. (See <a class="local">'Diarrhea'</a> above and  <a class="medical medical_review" href="/z/d/html/2717.html" rel="external">"Approach to the adult with acute diarrhea in resource-abundant settings"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Constipation – The maintenance of adequate hydration and administration of laxatives (eg, polyethylene glycol, magnesium-containing laxatives) for the treatment of constipation is typically required. If these measures fail, concentrated nonabsorbable sugar alcohols (eg, <a class="drug drug_general" data-topicid="9940" href="/z/d/drug information/9940.html" rel="external">sorbitol</a>, <a class="drug drug_general" data-topicid="9543" href="/z/d/drug information/9543.html" rel="external">lactulose</a>) or enemas may be required. (See <a class="local">'Constipation'</a> above and  <a class="medical medical_review" href="/z/d/html/2636.html" rel="external">"Management of chronic constipation in adults"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Electrolyte disturbance – Adverse metabolic consequences of EN include hyperglycemia, micronutrient deficiencies, and electrolyte abnormalities (including hyper-/hypokalemia and hyper-/hypophosphatemia). Daily electrolyte monitoring is required until stable. (See <a class="local">'Fluid/water/electrolyte disturbance'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Feeding tube complications, refeeding syndrome, bezoars – Feeding tube complications, refeeding syndrome, and fiber bezoars are uncommon complications of EN. Further details regarding these complications are described separately. (See  <a class="medical medical_review" href="/z/d/html/15070.html" rel="external">"Inpatient placement and management of nasogastric and nasoenteric tubes in adults", section on 'Complications'</a> and  <a class="medical medical_review" href="/z/d/html/2552.html" rel="external">"Gastrostomy tubes: Complications and their management"</a> and  <a class="medical medical_review" href="/z/d/html/15778.html" rel="external">"Anorexia nervosa in adults and adolescents: The refeeding syndrome"</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Compher C, Bingham AL, McCall M, et al. Guidelines for the provision of nutrition support therapy in the adult critically ill patient: The American Society for Parenteral and Enteral Nutrition. JPEN J Parenter Enteral Nutr 2022; 46:12.</a></li><li><a class="nounderline abstract_t">McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 2016; 40:159.</a></li><li class="breakAll">Nestle Nutrition products http://www.nestle-nutrition.com/Products/Default.aspx (Accessed on July 07, 2008).</li><li class="breakAll">Abbott Nutrition products http://abbottnutrition.com/products/index.aspx (Accessed on May 11, 2018).</li><li><a class="nounderline abstract_t">McMahon MM, Nystrom E, Braunschweig C, et al. A.S.P.E.N. clinical guidelines: nutrition support of adult patients with hyperglycemia. JPEN J Parenter Enteral Nutr 2013; 37:23.</a></li><li><a class="nounderline abstract_t">TARGET Investigators, for the ANZICS Clinical Trials Group, Chapman M, Peake SL, et al. Energy-Dense versus Routine Enteral Nutrition in the Critically Ill. N Engl J Med 2018; 379:1823.</a></li><li><a class="nounderline abstract_t">Fick TE, van Rooyen W, Eeftinck Schattenkerk M, et al. A nonelemental versus an elemental diet for early postoperative enteral feeding by needle catheter jejunostomy. Clin Nutr 1986; 5:105.</a></li><li><a class="nounderline abstract_t">Seres DS, Ippolito PR. Pilot study evaluating the efficacy, tolerance and safety of a peptide-based enteral formula versus a high protein enteral formula in multiple ICU settings (medical, surgical, cardiothoracic). Clin Nutr 2017; 36:706.</a></li><li><a class="nounderline abstract_t">Ford EG, Hull SF, Jennings LM, Andrassy RJ. Clinical comparison of tolerance to elemental or polymeric enteral feedings in the postoperative patient. J Am Coll Nutr 1992; 11:11.</a></li><li><a class="nounderline abstract_t">van den Berg B, Stam H. Metabolic and respiratory effects of enteral nutrition in patients during mechanical ventilation. Intensive Care Med 1988; 14:206.</a></li><li><a class="nounderline abstract_t">van den Berg B, Bogaard JM, Hop WC. High fat, low carbohydrate, enteral feeding in patients weaning from the ventilator. Intensive Care Med 1994; 20:470.</a></li><li><a class="nounderline abstract_t">al-Saady NM, Blackmore CM, Bennett ED. High fat, low carbohydrate, enteral feeding lowers PaCO2 and reduces the period of ventilation in artificially ventilated patients. Intensive Care Med 1989; 15:290.</a></li><li><a class="nounderline abstract_t">Mesejo A, Acosta JA, Ortega C, et al. Comparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients. Clin Nutr 2003; 22:295.</a></li><li><a class="nounderline abstract_t">Garrel DR, Razi M, Larivière F, et al. Improved clinical status and length of care with low-fat nutrition support in burn patients. JPEN J Parenter Enteral Nutr 1995; 19:482.</a></li><li><a class="nounderline abstract_t">Alexander JW. Immunonutrition: the role of omega-3 fatty acids. Nutrition 1998; 14:627.</a></li><li><a class="nounderline abstract_t">Pontes-Arruda A, Aragão AM, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 2006; 34:2325.</a></li><li><a class="nounderline abstract_t">Lu C, Sharma S, McIntyre L, et al. Omega-3 supplementation in patients with sepsis: a systematic review and meta-analysis of randomized trials. Ann Intensive Care 2017; 7:58.</a></li><li><a class="nounderline abstract_t">Singer P, Theilla M, Fisher H, et al. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 2006; 34:1033.</a></li><li><a class="nounderline abstract_t">Gadek JE, DeMichele SJ, Karlstad MD, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 1999; 27:1409.</a></li><li><a class="nounderline abstract_t">Rice TW, Wheeler AP, Thompson BT, et al. Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA 2011; 306:1574.</a></li><li><a class="nounderline abstract_t">Stapleton RD, Martin TR, Weiss NS, et al. A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med 2011; 39:1655.</a></li><li><a class="nounderline abstract_t">Dushianthan A, Cusack R, Burgess VA, et al. Immunonutrition for acute respiratory distress syndrome (ARDS) in adults. Cochrane Database Syst Rev 2019; 1:CD012041.</a></li><li><a class="nounderline abstract_t">Langlois PL, Hardy G, Manzanares W. Omega-3 polyunsaturated fatty acids in cardiac surgery patients: An updated systematic review and meta-analysis. Clin Nutr 2017; 36:737.</a></li><li><a class="nounderline abstract_t">Tao KM, Li XQ, Yang LQ, et al. Glutamine supplementation for critically ill adults. Cochrane Database Syst Rev 2014; :CD010050.</a></li><li><a class="nounderline abstract_t">Tan HB, Danilla S, Murray A, et al. Immunonutrition as an adjuvant therapy for burns. Cochrane Database Syst Rev 2014; :CD007174.</a></li><li><a class="nounderline abstract_t">Heyland DK, Dhaliwal R, Drover JW, et al. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr 2003; 27:355.</a></li><li><a class="nounderline abstract_t">Viana MV, Becce F, Pantet O, et al. Impact of β-hydroxy-β-methylbutyrate (HMB) on muscle loss and protein metabolism in critically ill patients: A RCT. Clin Nutr 2021; 40:4878.</a></li><li><a class="nounderline abstract_t">Nakamura K, Kihata A, Naraba H, et al. β-Hydroxy-β-methylbutyrate, Arginine, and Glutamine Complex on Muscle Volume Loss in Critically Ill Patients: A Randomized Control Trial. JPEN J Parenter Enteral Nutr 2020; 44:205.</a></li><li><a class="nounderline abstract_t">Lee ZY, Lew CCH, Ortiz-Reyes A, et al. Benefits and harm of probiotics and synbiotics in adult critically ill patients. A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. Clin Nutr 2023; 42:519.</a></li><li><a class="nounderline abstract_t">Hart GK, Dobb GJ. Effect of a fecal bulking agent on diarrhea during enteral feeding in the critically ill. JPEN J Parenter Enteral Nutr 1988; 12:465.</a></li><li><a class="nounderline abstract_t">Dobb GJ, Towler SC. Diarrhoea during enteral feeding in the critically ill: a comparison of feeds with and without fibre. Intensive Care Med 1990; 16:252.</a></li><li><a class="nounderline abstract_t">Allingstrup M, Afshari A. Selenium supplementation for critically ill adults. Cochrane Database Syst Rev 2015; :CD003703.</a></li><li><a class="nounderline abstract_t">Putzu A, Daems AM, Lopez-Delgado JC, et al. The Effect of Vitamin C on Clinical Outcome in Critically Ill Patients: A Systematic Review With Meta-Analysis of Randomized Controlled Trials. Crit Care Med 2019; 47:774.</a></li><li><a class="nounderline abstract_t">Gudivada KK, Kumar A, Sriram K, et al. Antioxidant micronutrient supplements for adult critically ill patients: A bayesian multiple treatment comparisons meta-analysis. Clin Nutr ESPEN 2022; 47:78.</a></li><li><a class="nounderline abstract_t">van Zanten AR, Sztark F, Kaisers UX, et al. High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial. JAMA 2014; 312:514.</a></li><li><a class="nounderline abstract_t">Zhang YP, Wan YD, Sun TW, et al. Association between vitamin D deficiency and mortality in critically ill adult patients: a meta-analysis of cohort studies. Crit Care 2014; 18:684.</a></li><li><a class="nounderline abstract_t">Amrein K, Schnedl C, Holl A, et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. JAMA 2014; 312:1520.</a></li><li><a class="nounderline abstract_t">Bonten MJ, Gaillard CA, van der Hulst R, et al. Intermittent enteral feeding: the influence on respiratory and digestive tract colonization in mechanically ventilated intensive-care-unit patients. Am J Respir Crit Care Med 1996; 154:394.</a></li><li><a class="nounderline abstract_t">Steevens EC, Lipscomb AF, Poole GV, Sacks GS. Comparison of continuous vs intermittent nasogastric enteral feeding in trauma patients: perceptions and practice. Nutr Clin Pract 2002; 17:118.</a></li><li><a class="nounderline abstract_t">MacLeod JB, Lefton J, Houghton D, et al. Prospective randomized control trial of intermittent versus continuous gastric feeds for critically ill trauma patients. J Trauma 2007; 63:57.</a></li><li><a class="nounderline abstract_t">Metheny N, Eisenberg P, McSweeney M. Effect of feeding tube properties and three irrigants on clogging rates. Nurs Res 1988; 37:165.</a></li><li><a class="nounderline abstract_t">Mentec H, Dupont H, Bocchetti M, et al. Upper digestive intolerance during enteral nutrition in critically ill patients: frequency, risk factors, and complications. Crit Care Med 2001; 29:1955.</a></li><li><a class="nounderline abstract_t">McClave SA, Lukan JK, Stefater JA, et al. Poor validity of residual volumes as a marker for risk of aspiration in critically ill patients. Crit Care Med 2005; 33:324.</a></li><li><a class="nounderline abstract_t">Montejo JC, Miñambres E, Bordejé L, et al. Gastric residual volume during enteral nutrition in ICU patients: the REGANE study. Intensive Care Med 2010; 36:1386.</a></li><li><a class="nounderline abstract_t">Reignier J, Mercier E, Le Gouge A, et al. Effect of not monitoring residual gastric volume on risk of ventilator-associated pneumonia in adults receiving mechanical ventilation and early enteral feeding: a randomized controlled trial. JAMA 2013; 309:249.</a></li><li><a class="nounderline abstract_t">Gleeson K, Eggli DF, Maxwell SL. Quantitative aspiration during sleep in normal subjects. Chest 1997; 111:1266.</a></li><li><a class="nounderline abstract_t">Niël-Weise BS, Gastmeier P, Kola A, et al. An evidence-based recommendation on bed head elevation for mechanically ventilated patients. Crit Care 2011; 15:R111.</a></li><li><a class="nounderline abstract_t">Drakulovic MB, Torres A, Bauer TT, et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999; 354:1851.</a></li><li><a class="nounderline abstract_t">van Nieuwenhoven CA, Vandenbroucke-Grauls C, van Tiel FH, et al. Feasibility and effects of the semirecumbent position to prevent ventilator-associated pneumonia: a randomized study. Crit Care Med 2006; 34:396.</a></li><li><a class="nounderline abstract_t">Keeley L. Reducing the risk of ventilator-acquired pneumonia through head of bed elevation. Nurs Crit Care 2007; 12:287.</a></li><li><a class="nounderline abstract_t">Llaurado-Serra M, Ulldemolins M, Fernandez-Ballart J, et al. Related factors to semi-recumbent position compliance and pressure ulcers in patients with invasive mechanical ventilation: An observational study (CAPCRI study). Int J Nurs Stud 2016; 61:198.</a></li><li><a class="nounderline abstract_t">Ho KM, Dobb GJ, Webb SA. A comparison of early gastric and post-pyloric feeding in critically ill patients: a meta-analysis. Intensive Care Med 2006; 32:639.</a></li><li><a class="nounderline abstract_t">Marik PE, Zaloga GP. Gastric versus post-pyloric feeding: a systematic review. Crit Care 2003; 7:R46.</a></li><li><a class="nounderline abstract_t">Heyland DK, Drover JW, Dhaliwal R, Greenwood J. Optimizing the benefits and minimizing the risks of enteral nutrition in the critically ill: role of small bowel feeding. JPEN J Parenter Enteral Nutr 2002; 26:S51.</a></li><li><a class="nounderline abstract_t">Gomes CA Jr, Andriolo RB, Bennett C, et al. Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances. Cochrane Database Syst Rev 2015; :CD008096.</a></li><li><a class="nounderline abstract_t">Bowman CA, Hutchins E, Burgermaster M, et al. Nasal Feeding Tubes Are Associated with Fewer Adverse Events than Feeding via Ostomy in Hospitalized Patients Receiving Enteral Nutrition. Am J Med 2022; 135:97.</a></li><li><a class="nounderline abstract_t">Yarmus L, Gilbert C, Lechtzin N, et al. Safety and feasibility of interventional pulmonologists performing bedside percutaneous endoscopic gastrostomy tube placement. Chest 2013; 144:436.</a></li><li><a class="nounderline abstract_t">Mitchell SL, Teno JM, Roy J, et al. Clinical and organizational factors associated with feeding tube use among nursing home residents with advanced cognitive impairment. JAMA 2003; 290:73.</a></li><li><a class="nounderline abstract_t">Arora G, Rockey D, Gupta S. High In-hospital mortality after percutaneous endoscopic gastrostomy: results of a nationwide population-based study. Clin Gastroenterol Hepatol 2013; 11:1437.</a></li><li><a class="nounderline abstract_t">Burgermaster M, Slattery E, Islam N, et al. Regional Comparison of Enteral Nutrition-Related Admission Policies in Skilled Nursing Facilities. Nutr Clin Pract 2016; 31:342.</a></li><li class="breakAll">Motility agents http://www.criticalcarenutrition.com/index.php?option=com_content&amp;task=view&amp;id=17&amp;Itemid=40 (Accessed on March 03, 2009).</li><li><a class="nounderline abstract_t">Liu Y, Dong X, Yang S, et al. Metoclopramide for preventing nosocomial pneumonia in patients fed via nasogastric tubes: a systematic review and meta-analysis of randomized controlled trials. Asia Pac J Clin Nutr 2017; 26:820.</a></li><li><a class="nounderline abstract_t">Lewis K, Alqahtani Z, Mcintyre L, et al. The efficacy and safety of prokinetic agents in critically ill patients receiving enteral nutrition: a systematic review and meta-analysis of randomized trials. Crit Care 2016; 20:259.</a></li><li><a class="nounderline abstract_t">Montejo JC. Enteral nutrition-related gastrointestinal complications in critically ill patients: a multicenter study. The Nutritional and Metabolic Working Group of the Spanish Society of Intensive Care Medicine and Coronary Units. Crit Care Med 1999; 27:1447.</a></li><li><a class="nounderline abstract_t">Luft VC, Beghetto MG, de Mello ED, Polanczyk CA. Role of enteral nutrition in the incidence of diarrhea among hospitalized adult patients. Nutrition 2008; 24:528.</a></li><li><a class="nounderline abstract_t">Taylor BE, McClave SA, Martindale RG, et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). Crit Care Med 2016; 44:390.</a></li><li><a class="nounderline abstract_t">Heather DJ, Howell L, Montana M, et al. Effect of a bulk-forming cathartic on diarrhea in tube-fed patients. Heart Lung 1991; 20:409.</a></li><li><a class="nounderline abstract_t">Spapen H, Diltoer M, Van Malderen C, et al. Soluble fiber reduces the incidence of diarrhea in septic patients receiving total enteral nutrition: a prospective, double-blind, randomized, and controlled trial. Clin Nutr 2001; 20:301.</a></li><li><a class="nounderline abstract_t">Rushdi TA, Pichard C, Khater YH. Control of diarrhea by fiber-enriched diet in ICU patients on enteral nutrition: a prospective randomized controlled trial. Clin Nutr 2004; 23:1344.</a></li><li><a class="nounderline abstract_t">Ruston T, Hunter K, Cummings G, Lazarescu A. Efficacy and side-effect profiles of lactulose, docusate sodium, and sennosides compared to PEG in opioid-induced constipation: a systematic review. Can Oncol Nurs J 2013; 23:236.</a></li><li><a class="nounderline abstract_t">da Silva JSV, Seres DS, Sabino K, et al. ASPEN Consensus Recommendations for Refeeding Syndrome. Nutr Clin Pract 2020; 35:178.</a></li><li><a class="nounderline abstract_t">McIvor AC, Meguid MM, Curtas S, et al. Intestinal obstruction from cecal bezoar; a complication of fiber-containing tube feedings. Nutrition 1990; 6:115.</a></li><li><a class="nounderline abstract_t">Scaife CL, Saffle JR, Morris SE. Intestinal obstruction secondary to enteral feedings in burn trauma patients. J Trauma 1999; 47:859.</a></li></ol></div><div id="topicVersionRevision">Topic 1605 Version 44.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34784064" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Guidelines for the provision of nutrition support therapy in the adult critically ill patient: The American Society for Parenteral and Enteral Nutrition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26773077" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26773077" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26773077" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22753619" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : A.S.P.E.N. clinical guidelines: nutrition support of adult patients with hyperglycemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30346225" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Energy-Dense versus Routine Enteral Nutrition in the Critically Ill.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16831755" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : A nonelemental versus an elemental diet for early postoperative enteral feeding by needle catheter jejunostomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27161892" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Pilot study evaluating the efficacy, tolerance and safety of a peptide-based enteral formula versus a high protein enteral formula in multiple ICU settings (medical, surgical, cardiothoracic).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1541787" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Clinical comparison of tolerance to elemental or polymeric enteral feedings in the postoperative patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3132490" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Metabolic and respiratory effects of enteral nutrition in patients during mechanical ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7995861" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : High fat, low carbohydrate, enteral feeding in patients weaning from the ventilator.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2504796" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : High fat, low carbohydrate, enteral feeding lowers PaCO2 and reduces the period of ventilation in artificially ventilated patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12765670" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Comparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8748363" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Improved clinical status and length of care with low-fat nutrition support in burn patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9684267" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Immunonutrition: the role of omega-3 fatty acids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16850002" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28585162" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Omega-3 supplementation in patients with sepsis: a systematic review and meta-analysis of randomized trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16484911" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10470743" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21976613" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21423000" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30677127" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Immunonutrition for acute respiratory distress syndrome (ARDS) in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27293143" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Omega-3 polyunsaturated fatty acids in cardiac surgery patients: An updated systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25199493" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Glutamine supplementation for critically ill adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25536183" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Immunonutrition as an adjuvant therapy for burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12971736" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34358832" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Impact ofβ-hydroxy-β-methylbutyrate (HMB) on muscle loss and protein metabolism in critically ill patients: A RCT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31134640" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : β-Hydroxy-β-methylbutyrate, Arginine, and Glutamine Complex on Muscle Volume Loss in Critically Ill Patients: A Randomized Control Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36857961" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Benefits and harm of probiotics and synbiotics in adult critically ill patients. A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3141642" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Effect of a fecal bulking agent on diarrhea during enteral feeding in the critically ill.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2162867" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Diarrhoea during enteral feeding in the critically ill: a comparison of feeds with and without fibre.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26214143" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Selenium supplementation for critically ill adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30839358" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The Effect of Vitamin C on Clinical Outcome in Critically Ill Patients: A Systematic Review With Meta-Analysis of Randomized Controlled Trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35063246" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Antioxidant micronutrient supplements for adult critically ill patients: A bayesian multiple treatment comparisons meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25096691" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25498305" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Association between vitamin D deficiency and mortality in critically ill adult patients: a meta-analysis of cohort studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25268295" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8756812" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Intermittent enteral feeding: the influence on respiratory and digestive tract colonization in mechanically ventilated intensive-care-unit patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16214974" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Comparison of continuous vs intermittent nasogastric enteral feeding in trauma patients: perceptions and practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17622869" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Prospective randomized control trial of intermittent versus continuous gastric feeds for critically ill trauma patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3130615" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Effect of feeding tube properties and three irrigants on clogging rates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11588461" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Upper digestive intolerance during enteral nutrition in critically ill patients: frequency, risk factors, and complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15699835" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Poor validity of residual volumes as a marker for risk of aspiration in critically ill patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20232036" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Gastric residual volume during enteral nutrition in ICU patients: the REGANE study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23321763" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Effect of not monitoring residual gastric volume on risk of ventilator-associated pneumonia in adults receiving mechanical ventilation and early enteral feeding: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9149581" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Quantitative aspiration during sleep in normal subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21481251" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : An evidence-based recommendation on bed head elevation for mechanically ventilated patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10584721" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16424720" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Feasibility and effects of the semirecumbent position to prevent ventilator-associated pneumonia: a randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17983363" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Reducing the risk of ventilator-acquired pneumonia through head of bed elevation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27394032" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Related factors to semi-recumbent position compliance and pressure ulcers in patients with invasive mechanical ventilation: An observational study (CAPCRI study).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16570149" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : A comparison of early gastric and post-pyloric feeding in critically ill patients: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12793890" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Gastric versus post-pyloric feeding: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12405623" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Optimizing the benefits and minimizing the risks of enteral nutrition in the critically ill: role of small bowel feeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25997528" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34543647" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Nasal Feeding Tubes Are Associated with Fewer Adverse Events than Feeding via Ostomy in Hospitalized Patients Receiving Enteral Nutrition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23392239" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Safety and feasibility of interventional pulmonologists performing bedside percutaneous endoscopic gastrostomy tube placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12837714" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Clinical and organizational factors associated with feeding tube use among nursing home residents with advanced cognitive impairment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23602822" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : High In-hospital mortality after percutaneous endoscopic gastrostomy: results of a nationwide population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26993318" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Regional Comparison of Enteral Nutrition-Related Admission Policies in Skilled Nursing Facilities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26993318" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Regional Comparison of Enteral Nutrition-Related Admission Policies in Skilled Nursing Facilities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28802291" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Metoclopramide for preventing nosocomial pneumonia in patients fed via nasogastric tubes: a systematic review and meta-analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27527069" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : The efficacy and safety of prokinetic agents in critically ill patients receiving enteral nutrition: a systematic review and meta-analysis of randomized trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10470748" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Enteral nutrition-related gastrointestinal complications in critically ill patients: a multicenter study. The Nutritional and Metabolic Working Group of the Spanish Society of Intensive Care Medicine and Coronary Units.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18417321" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Role of enteral nutrition in the incidence of diarrhea among hospitalized adult patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26771786" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1906447" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Effect of a bulk-forming cathartic on diarrhea in tube-fed patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11478826" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Soluble fiber reduces the incidence of diarrhea in septic patients receiving total enteral nutrition: a prospective, double-blind, randomized, and controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15556256" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Control of diarrhea by fiber-enriched diet in ICU patients on enteral nutrition: a prospective randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24428006" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Efficacy and side-effect profiles of lactulose, docusate sodium, and sennosides compared to PEG in opioid-induced constipation: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32115791" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : ASPEN Consensus Recommendations for Refeeding Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1966944" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Intestinal obstruction from cecal bezoar; a complication of fiber-containing tube feedings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10568712" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Intestinal obstruction secondary to enteral feedings in burn trauma patients.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
